Skip to main content
Top
Published in: Journal of Neurology 7/2012

01-07-2012 | Original Communication

Screening for balance disorders in mildly affected multiple sclerosis patients

Authors: Malou H. J. Fanchamps, Henrik Gensicke, Jens Kuhle, Ludwig Kappos, John H. J. Allum, Özgür Yaldizli

Published in: Journal of Neurology | Issue 7/2012

Login to get access

Abstract

Multiple sclerosis (MS) patients often complain about balance problems when Romberg’s test and tandem gait are normal. The aim of the study was to determine if measures of trunk sway taken during a battery of stance and gait tasks could be used to detect subclinical balance disorders. We recorded trunk angular sway in the pitch and roll directions from 20 MS patients (EDSS 1.4 ± 0.5) and 20 age- and gender-matched healthy controls (HCs), during 12 stance and gait tasks. We filmed 22 subjects simultaneously. Two neurologists assessed the videos, deciding whether task performance was pathological. Sway measures were significantly different between patients and HCs in eight out of 12 balance tasks. The most significant differences between MS patients and HCs were pitch angle range standing on one leg with eyes open on a firm surface (mean 3.13° vs. 2.09°, p = 0.005), and on a foam support surface (mean 6.24° vs. 2.96°, p = 0.006), pitch velocity range walking 8 m with eyes closed (mean 75.5 vs. 50.2°/s, p < 0.001) and pitch velocity range walking 3 m on heels (mean 85.37 vs. 60.9°/s, p = 0.002). Multivariate analysis revealed a model with three tasks which detected balance disorders in 84% of the MS patients and 90% of the HCs correctly. The neurologists achieved accuracies of 30% for the MS patients and 82% for the HCs. Using trunk sway measures during stance and gait tasks is a sensitive screening method for balance problems in MS patients, and is more accurate than assessment by trained neurologists.
Literature
1.
go back to reference Corradini ML, Fioretti S, Leo T, Piperno R (1997) Early recognition of postural disorders in multiple sclerosis through movement analysis: a modeling study. IEEE Trans Biomed Eng 44:1029–1038PubMedCrossRef Corradini ML, Fioretti S, Leo T, Piperno R (1997) Early recognition of postural disorders in multiple sclerosis through movement analysis: a modeling study. IEEE Trans Biomed Eng 44:1029–1038PubMedCrossRef
2.
go back to reference Karst GM, Venema DM, Roehrs TG, Tyler AE (2005) Center of pressure measures during standing tasks in minimally impaired persons with multiple sclerosis. J Neurol Phys Ther 29:170–180PubMed Karst GM, Venema DM, Roehrs TG, Tyler AE (2005) Center of pressure measures during standing tasks in minimally impaired persons with multiple sclerosis. J Neurol Phys Ther 29:170–180PubMed
3.
go back to reference Gensicke H, Corporaal S, Kappos L, Allum J, Yaldizli Ö (2011) Correlations of balance instability and disability in multiple sclerosis patients [abstract]. J Neurol 258:P92 Gensicke H, Corporaal S, Kappos L, Allum J, Yaldizli Ö (2011) Correlations of balance instability and disability in multiple sclerosis patients [abstract]. J Neurol 258:P92
4.
go back to reference Soyuer F, Mirza M, Erkorkmaz U (2006) Balance performance in three forms of multiple sclerosis. Neurol Res 28:555–562PubMedCrossRef Soyuer F, Mirza M, Erkorkmaz U (2006) Balance performance in three forms of multiple sclerosis. Neurol Res 28:555–562PubMedCrossRef
5.
go back to reference Cattaneo D, Cardini R (2001) Computerized system to improve voluntary control of balance in neurological patients. Cyberpsychol Behav 4:687–694PubMedCrossRef Cattaneo D, Cardini R (2001) Computerized system to improve voluntary control of balance in neurological patients. Cyberpsychol Behav 4:687–694PubMedCrossRef
6.
go back to reference Cakt BD, Nacir B, Genc H, Saracoglu M, Karagoz A, Erdem HR et al (2010) Cycling progressive resistance training for people with multiple sclerosis: a randomized controlled study. Am J Phys Med Rehabil 89:446–457PubMedCrossRef Cakt BD, Nacir B, Genc H, Saracoglu M, Karagoz A, Erdem HR et al (2010) Cycling progressive resistance training for people with multiple sclerosis: a randomized controlled study. Am J Phys Med Rehabil 89:446–457PubMedCrossRef
7.
go back to reference Missaoui B, Thoumie P (2009) How far do patients with sensory ataxia benefit from so-called “proprioceptive rehabilitation”? Neurophysiol Clin 39:229–233PubMedCrossRef Missaoui B, Thoumie P (2009) How far do patients with sensory ataxia benefit from so-called “proprioceptive rehabilitation”? Neurophysiol Clin 39:229–233PubMedCrossRef
8.
go back to reference Widener GL, Allen DD, Gibson-Horn C (2009) Randomized clinical trial of balance-based torso weighting for improving upright mobility in people with multiple sclerosis. Neurorehabil Neural Repair 23:784–791PubMedCrossRef Widener GL, Allen DD, Gibson-Horn C (2009) Randomized clinical trial of balance-based torso weighting for improving upright mobility in people with multiple sclerosis. Neurorehabil Neural Repair 23:784–791PubMedCrossRef
9.
go back to reference Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58:840–846PubMedCrossRef Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58:840–846PubMedCrossRef
10.
go back to reference Jacobson GP, Newman CW (1990) The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 116:424–427PubMedCrossRef Jacobson GP, Newman CW (1990) The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 116:424–427PubMedCrossRef
11.
go back to reference Cattaneo D, Jonsdottir J, Zocchi M, Regola A (2007) Effects of balance exercises on people with multiple sclerosis: a pilot study. Clin Rehabil 21:771–781PubMedCrossRef Cattaneo D, Jonsdottir J, Zocchi M, Regola A (2007) Effects of balance exercises on people with multiple sclerosis: a pilot study. Clin Rehabil 21:771–781PubMedCrossRef
12.
go back to reference Cameron MH, Horak FB, Herndon RR, Bourdette D (2008) Imbalance in multiple sclerosis: a result of slowed spinal somatosensory conduction. Somatosens Mot Res 25:113–122PubMedCrossRef Cameron MH, Horak FB, Herndon RR, Bourdette D (2008) Imbalance in multiple sclerosis: a result of slowed spinal somatosensory conduction. Somatosens Mot Res 25:113–122PubMedCrossRef
13.
go back to reference Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E et al (2006) Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 12:620–628PubMedCrossRef Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E et al (2006) Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 12:620–628PubMedCrossRef
14.
go back to reference Findling O, Sellner J, Meier N, Allum JH, Vibert D, Lienert C et al (2011) Trunk sway in mildly disabled multiple sclerosis patients with and without balance impairment. Exp Brain Res 213:363–370PubMedCrossRef Findling O, Sellner J, Meier N, Allum JH, Vibert D, Lienert C et al (2011) Trunk sway in mildly disabled multiple sclerosis patients with and without balance impairment. Exp Brain Res 213:363–370PubMedCrossRef
15.
go back to reference Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH (2009) Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler 15:918–927PubMedCrossRef Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH (2009) Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler 15:918–927PubMedCrossRef
16.
go back to reference Hegeman J, Shapkova EY, Honegger F, Allum JH (2007) Effect of age and height on trunk sway during stance and gait. J Vestib Res 17:75–87PubMed Hegeman J, Shapkova EY, Honegger F, Allum JH (2007) Effect of age and height on trunk sway during stance and gait. J Vestib Res 17:75–87PubMed
17.
go back to reference (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 352:1498–504 (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 352:1498–504
18.
go back to reference IFNB Multiple Scleriosis Study Group (2001) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article]. Neurology 57:S3–S9 IFNB Multiple Scleriosis Study Group (2001) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article]. Neurology 57:S3–S9
19.
go back to reference Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM et al (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The multiple sclerosis collaborative research group (MSCRG). Ann Neurol 39:285–294PubMedCrossRef Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM et al (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The multiple sclerosis collaborative research group (MSCRG). Ann Neurol 39:285–294PubMedCrossRef
20.
go back to reference Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The copolymer 1 multiple sclerosis study group. Neurology 45:1268–1276PubMedCrossRef Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The copolymer 1 multiple sclerosis study group. Neurology 45:1268–1276PubMedCrossRef
21.
go back to reference Polman CH, O’Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899–910PubMedCrossRef Polman CH, O’Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899–910PubMedCrossRef
22.
go back to reference Brandes DW, Shaya FT, Pill MW (2010) Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis. Am J Manag Care 16:S171–S177PubMed Brandes DW, Shaya FT, Pill MW (2010) Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis. Am J Manag Care 16:S171–S177PubMed
Metadata
Title
Screening for balance disorders in mildly affected multiple sclerosis patients
Authors
Malou H. J. Fanchamps
Henrik Gensicke
Jens Kuhle
Ludwig Kappos
John H. J. Allum
Özgür Yaldizli
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 7/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6366-5

Other articles of this Issue 7/2012

Journal of Neurology 7/2012 Go to the issue